Form 4: AnaptysBio CLO Sells Shares for Tax Obligations

AnaptysBio's Chief Legal Officer, Eric J. Loumeau, sold 2,983 shares of common stock for $43.26 per share to cover tax withholding obligations following the vesting of restricted stock units.

Summary

• Eric J. Loumeau, Chief Legal Officer of AnaptysBio, Inc., reported transactions involving the company's common stock.
• On January 3, 2026, 7,287 restricted stock units (RSUs) vested and settled into 7,287 shares of common stock.
• Each RSU represents a contingent right to receive one share of the Issuer's Common Stock for no consideration.
• Following this RSU settlement, Loumeau beneficially owned 16,234 shares of common stock directly.
• On January 5, 2026, Loumeau sold 2,983 shares of common stock at a price of $43.26 per share.
• This sale was a "sell to cover" transaction to satisfy tax withholding obligations related to the RSU vesting and was not a discretionary transaction.
• After the sale, Loumeau directly beneficially owned 13,251 shares of common stock.
• The RSUs vest as to 25% of the total annually commencing on January 3, 2025, subject to continued service.

Sentiment

Score: 6

Explanation: The filing reports the vesting of restricted stock units for a key executive, which is a positive for executive retention. The subsequent sale of shares was explicitly for tax withholding purposes, a routine and non-discretionary event, thus having a neutral impact on sentiment.

Positives

• The vesting of 7,287 restricted stock units indicates continued compensation and retention of a key executive.

Negatives

• The sale of 2,983 shares, even for tax purposes, reduces the insider's direct ownership in the company.

Future Outlook

NA

Management Comments

• The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
• The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Industry Context

NA

Stakeholder Impact

• Shareholders: Minor dilution from RSU settlement, but the 'sell to cover' is a routine event and not indicative of a lack of confidence.
• Employees (specifically Eric J. Loumeau): Continued compensation through equity, subject to service.

Next Steps

• Continued annual vesting of remaining restricted stock units on January 3rd of subsequent years, subject to continued service.

Key Dates

Recommendation

This Form 4 details a routine insider transaction where the Chief Legal Officer sold shares to cover tax obligations arising from RSU vesting. Such 'sell to cover' transactions are non-discretionary and do not typically signal a change in management's outlook or confidence in the company. Therefore, this filing alone does not provide a basis for a 'buy' or 'sell' recommendation, maintaining a 'hold' stance based solely on this information.

Keywords

AnaptysBio, ANAB, Form 4, Insider Trading, Restricted Stock Units, RSU, Sell to Cover, Executive Compensation, Eric J. Loumeau, Chief Legal Officer